User profiles for Adeera Levin
adeera levinProfessor of medicine university of British columbia Verified email at providencehealth.bc.ca Cited by 99375 |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney …
A Levin, PE Stevens, RW Bilous… - Kidney international …, 2013 - pure.johnshopkins.edu
The Kidney Disease: Improving Global Outcomes (KDIGO) 2012 Clinical Practice Guideline
for the Evaluation and Management of Chronic Kidney Disease (CKD) serves to update the …
for the Evaluation and Management of Chronic Kidney Disease (CKD) serves to update the …
[HTML][HTML] Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Introduction Acute kidney injury (AKI) is a complex disorder for which currently there is no
accepted definition. Having a uniform standard for diagnosing and classifying AKI would …
accepted definition. Having a uniform standard for diagnosing and classifying AKI would …
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification
Chronic kidney disease is a worldwide public health problem with an increasing incidence
and prevalence, poor outcomes, and high cost. Outcomes of chronic kidney disease include …
and prevalence, poor outcomes, and high cost. Outcomes of chronic kidney disease include …
[HTML][HTML] Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
… D., The Netherlands; Martin Kuhlmann, MD, United States; Norbert Lameire, MD, Belgium;
Andrew Levey, MD, United States; Adeera Levin, MD, FRCPC, Canada; Nathan Levin, MD, …
Andrew Levey, MD, United States; Adeera Levin, MD, FRCPC, Canada; Nathan Levin, MD, …
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification
…, A Kausz, PL Kimmel, J Kusek, A Levin… - American Journal of …, 2002 - jhu.pure.elsevier.com
Introduction: Chronic kidney disease as a public health problem. Chronic kidney disease is
a worldwide public health problem. In the United States, there is a rising incidence and …
a worldwide public health problem. In the United States, there is a rising incidence and …
[HTML][HTML] Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
Background Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few
effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–…
effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–…
[HTML][HTML] The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a …
Background Lowering LDL cholesterol with statin regimens reduces the risk of myocardial
infarction, ischaemic stroke, and the need for coronary revascularisation in people without …
infarction, ischaemic stroke, and the need for coronary revascularisation in people without …
Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline
PE Stevens, A Levin… - Annals of internal …, 2013 - acpjournals.org
Chinese translation Description: The Kidney Disease: Improving Global Outcomes (KDIGO)
organization developed clinical practice guidelines in 2012 to provide guidance on the …
organization developed clinical practice guidelines in 2012 to provide guidance on the …
Bone metabolism and disease in chronic kidney disease
G Eknoyan, A Levin, NW Levin - American Journal of Kidney Diseases, 2003 - ajkd.org
Disturbances in mineral and bone metabolism are common in patients with CKD. A large
body of evidence indicates that these derangements are associated with increased mortality …
body of evidence indicates that these derangements are associated with increased mortality …
Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin
A Levin, CR Thompson, J Ethier, EJF Carlisle… - American Journal of …, 1999 - Elsevier
Cardiovascular disease occurs in patients with progressive renal disease both before and
after the initiation of dialysis. Left ventricular hypertrophy (LVH) is an independent predictor of …
after the initiation of dialysis. Left ventricular hypertrophy (LVH) is an independent predictor of …